Literature DB >> 16210908

Basophils, basophilia and helminth infections.

Edward Mitre1, Thomas B Nutman.   

Abstract

A growing body of evidence suggests basophils are important components of the human immune response to helminth infections. Basophil numbers are increased in several animal models of helminth infection, and basophils have been shown to release both histamine and IL-4 in response to helminths. Helminth infections typically provoke type 2 immune responses characterized by eosinophilia, elevated levels of Ag-specific and polyclonal IgE, and T cell production of type 2 cytokines such as IL-4, IL-5, and IL-13. IL-4 plays a central role in this type 2 response. As basophils are the only peripheral blood mononuclear cells with the ability to release IL-4 rapidly in response to appropriate stimuli, releasing large quantities of preformed IL-4 within minutes of surface IgE cross-linking, it appears likely that basophils play an important role in amplifying ongoing type 2 immune responses to helminth infections once Ag-specific IgE is present. Basophils may also function to initiate type 2 responses upon first exposure to helminths and to potentially re-establish these responses upon re-exposure. This article reviews basic basophil biology and physiology, evaluates the evidence for the presence of basophilia in helminth infections, and then focuses on the possible roles basophils serve in the immune response to helminth infections.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16210908     DOI: 10.1159/000088886

Source DB:  PubMed          Journal:  Chem Immunol Allergy        ISSN: 0079-6034


  13 in total

Review 1.  State-of-the-art review about basophil research in immunology and allergy: is the time right to treat these cells with the respect they deserve?

Authors:  Salvatore Chirumbolo
Journal:  Blood Transfus       Date:  2011-12-21       Impact factor: 3.443

Review 2.  Basophils and type 2 immunity.

Authors:  Booki Min; William E Paul
Journal:  Curr Opin Hematol       Date:  2008-01       Impact factor: 3.284

Review 3.  Cell Type-Specific Immunomodulation Induced by Helminthes: Effect on Metainflammation, Insulin Resistance and Type-2 Diabetes.

Authors:  Vivekanandhan Aravindhan; Gowrishankar Anand
Journal:  Am J Trop Med Hyg       Date:  2017-10-26       Impact factor: 2.345

Review 4.  Basophil-derived IL-4 plays versatile roles in immunity.

Authors:  Yoshinori Yamanishi; Hajime Karasuyama
Journal:  Semin Immunopathol       Date:  2016-05-10       Impact factor: 9.623

5.  Pleural cavity type 2 innate lymphoid cells precede Th2 expansion in murine Litomosoides sigmodontis infection.

Authors:  Alexis Boyd; Kristin Killoran; Edward Mitre; Thomas B Nutman
Journal:  Exp Parasitol       Date:  2015-09-21       Impact factor: 2.011

6.  Anti-scratching behavioral effects of N-stearoyl-phytosphingosine and 4-hydroxysphinganine in mice.

Authors:  Kwon-Ryeol Ryu; Bomi Lee; In-Ah Lee; Sekwan Oh; Dong-Hyun Kim
Journal:  Lipids       Date:  2010-06-29       Impact factor: 1.880

7.  Chronic helminth infection reduces basophil responsiveness in an IL-10-dependent manner.

Authors:  David Larson; Marc P Hübner; Marina N Torrero; Christopher P Morris; Amy Brankin; Brett E Swierczewski; Stephen J Davies; Becky M Vonakis; Edward Mitre
Journal:  J Immunol       Date:  2012-03-28       Impact factor: 5.422

8.  Basophils help establish protective immunity induced by irradiated larval vaccination for filariasis.

Authors:  Marina N Torrero; C Paul Morris; Blima K Mitre; Marc P Hübner; Ellen M Fox; Hajime Karasuyama; Edward Mitre
Journal:  Vaccine       Date:  2013-06-15       Impact factor: 3.641

9.  CD200R surface expression as a marker of murine basophil activation.

Authors:  M N Torrero; D Larson; M P Hübner; E Mitre
Journal:  Clin Exp Allergy       Date:  2008-12-23       Impact factor: 5.018

10.  Omega-1, a glycoprotein secreted by Schistosoma mansoni eggs, drives Th2 responses.

Authors:  Bart Everts; Georgia Perona-Wright; Hermelijn H Smits; Cornelis H Hokke; Alwin J van der Ham; Colin M Fitzsimmons; Michael J Doenhoff; Jürgen van der Bosch; Katja Mohrs; Helmut Haas; Markus Mohrs; Maria Yazdanbakhsh; Gabriele Schramm
Journal:  J Exp Med       Date:  2009-07-27       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.